国际眼科纵览

• 综述 • 上一篇    下一篇

真菌性角膜炎治疗进展

刘欣  曾庆延   

  1. 410100 长沙,中南大学爱尔眼科学院(刘欣、曾庆延);430020 武汉,汉口爱尔眼科医院(曾庆延)
  • 收稿日期:2015-01-16 出版日期:2015-12-22 发布日期:2015-12-22
  • 通讯作者: 曾庆延,Email:zengqingyan1972@163.com
  • 基金资助:

    武汉市卫计委临床医学科研项目(WX13C50);爱尔眼科医院集团科研基金项目(AF2013006)

The advances in the treatment of fungal keratitis

LIU Xin1, ZENG Qing-yan1,2   

  1. 1. Aier School of Ophthalmology, Central South University, Changsha 410100, China; 2. Hankou Aier Eye Hospital, Wuhan 430020, China
  • Received:2015-01-16 Online:2015-12-22 Published:2015-12-22
  • Contact: ZENG Qing-yan, Email: zengqingyan1972@163.com

摘要:

真菌性角膜炎是一种严重的致盲性眼病,近年来治疗真菌性角膜炎新的药物有四代唑类、聚六甲基双胍、钙调磷酸酶抑制剂等,新药物剂型有凝胶缓释剂、克霉唑-β-环糊精等,新的手术方式有角膜胶原交联术、准分子激光治疗性角膜切削术、深板层角膜移植术等。(国际眼科纵览, 2015,  39:   386-390)

Abstract:

Fungal keratitis is a serious blindness leading disease. In recent years, new    treatment included new medicines such as fourth generation azoles, poly hexamethylene biguanide, calcineurin inhibitors, and new dosage forms such as mucoadhesive gels and Clotrimazole-β-Cyclodextrin, new operation such as corneal collagen cross-linking, excimer laser phototherapeutic keratectomy, deep lamellar keratoplasty, etc.   (Int Rev Ophthalmol,  2015,  39:     386-390)